「fea」の検索結果

Writes down what is being built so a team can build it and know when they are done — problem and success measure before solution, scope stated by exclusion, user-visible behavior including the states everyone forgets, acceptance criteria someone can test, and the open questions named rather than buried. Use this to write a specification, review one that is causing rework, or work out why a delivered feature technically matched the request and still was not what anyone wanted.

日本語の概要は準備中です。原文の説明を表示しています。

Writes and edits marketing copy for any surface — homepage, product and pricing pages, ads, emails, and collateral — and sharpens existing copy that is not working. Use this to write or rewrite page copy, tighten a draft, fix copy that is vague or feature-led, adapt one message across formats, or review copy before it ships.

日本語の概要は準備中です。原文の説明を表示しています。

Takes something built and gets it into the market — tiering the launch to match what it actually warrants, sequencing internal readiness before external announcement, preparing sales and support to answer the questions it creates, choosing the date for a reason, and measuring adoption rather than announcement reach. Use this to plan a launch, right-size one that is consuming more than it deserves, work out why a released feature nobody uses was launched loudly, or run the weeks after launch day.

日本語の概要は準備中です。原文の説明を表示しています。

Governs models and AI systems in production — intended use, evaluation, monitoring, human oversight, documentation, and the decision to deploy or retire. Use this before deploying a model or AI feature, when defining evaluation criteria, when a model's behavior has drifted, when assessing AI risk or regulatory exposure, or when deciding whether an AI system is fit for a consequential decision.

日本語の概要は準備中です。原文の説明を表示しています。

Lightweight guidance for using the Redis Rate Limit TypeScript SDK, including setup steps, basic usage, and pointers to advanced algorithm, features, pricing, and traffic‑protection docs.

日本語の概要は準備中です。原文の説明を表示しています。

Use when implementing any feature or bugfix, before writing implementation code

日本語の概要は準備中です。原文の説明を表示しています。

You MUST use this before any creative work - creating features, building components, adding functionality, or modifying behavior. Explores user intent, requirements and design before implementation.

日本語の概要は準備中です。原文の説明を表示しています。

FlyAI travel search and booking skill powered by Fliggy MCP. Search flights, hotels, attractions, trains, concerts, and travel deals with natural language. Supports diverse travel scenarios including individual, group, business, family trips. No API key required for basic features.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when adding authentication, handling user input, working with secrets, creating API endpoints, or implementing payment/sensitive features. Provides comprehensive security checklist and patterns.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when writing new features, fixing bugs, or refactoring code. Enforces test-driven development with 80%+ coverage including unit, integration, and E2E tests.

日本語の概要は準備中です。原文の説明を表示しています。

Land a change everywhere the same fact is stated — enumerating the full surface inventory (landing copy, docs, machine-readable summaries, changelog badges repeated across every page, sitemap, README, descriptions embedded in code, and untyped frontend consumers of typed responses), generating a surface instead of restating it, drift tests where you cannot generate, never hand-maintaining a copy of a surface another codebase owns, shipping a paired PR when you change a format a different codebase decodes, and keeping overloaded product words apart. Use when adding or renaming a user-facing feature, editing product/marketing copy or docs, renaming a serialized response field, changing a serialization or share-link format, wiring one repo's output into another's checks, or reviewing a PR that touched only one place a fact appears.

日本語の概要は準備中です。原文の説明を表示しています。

NGS analysis toolkit. Used for BAM to bigWig conversion, quality control (correlation, PCA, fingerprint plots), heatmaps/feature plots (TSS, peaks), suitable for ChIP-seq, RNA-seq, ATAC-seq visualization.

日本語の概要は準備中です。原文の説明を表示しています。

Simulate structured grant peer review for biomedical proposals; use when stress-testing significance, innovation, approach, feasibility, and reviewer-facing weaknesses before submission.

日本語の概要は準備中です。原文の説明を表示しています。

Designs a translational blueprint for moving a biomedical finding toward diagnosis, prognosis, treatment response prediction, patient stratification, or therapeutic development, with explicit translational milestones, validation thresholds, and feasibility-sensitive route framing.

日本語の概要は準備中です。原文の説明を表示しています。

Plans sample size estimation logic, power assumptions, feasibility checks, and fallback enrollment strategies for clinical and translational study protocols.

日本語の概要は準備中です。原文の説明を表示しています。

Designs studies for predicting treatment response or resistance in biomedical and clinical research. Always use this skill when the user needs a treatment-response or resistance prediction study blueprint rather than a prognostic biomarker protocol, diagnostic test design, causal treatment-effect estimation, or a completed manuscript. Focus on responder definition, treatment context, baseline comparability, feature integration strategy, model development logic, validation architecture, and interpretation boundaries. Do not invent response rates, cohort size, assay readiness, regimen uniformity, literature support, or validation access.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete comorbidity-oriented shared-biomarker bioinformatics research designs from a user-provided disease pair and validation direction. Use when a study links two clinically related diseases through shared DEGs, enrichment, PPI hub genes, machine-learning feature selection, public diagnostic validation, gene-regulatory networks, immune infiltration, and optional downstream follow-up. Covers five study patterns (shared-DEG discovery, hub-gene prioritization, machine-learning biomarker selection, immune/regulatory interpretation, multi-layer validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete process-related diagnostic biomarker bioinformatics research designs from a user-provided disease context, gene-family or pathway theme, and validation direction. Use when a study centers on process-related genes, DEG and WGCNA integration, machine-learning feature selection, nomogram-based diagnostic modeling, immune infiltration, regulatory-network analysis, and optional external or experimental validation. Covers five study patterns (process-DEG discovery, co-expression-module integration, machine-learning biomarker selection, diagnostic model/nomogram workflow, immune-regulatory interpretation and validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Designs primary, secondary, and exploratory endpoints for biomedical and clinical research protocols. Always use this skill when a user needs to translate study aims into operational endpoint definitions with event rules, assessment timing, composite logic, interpretability, and protocol-stage auditability. Focus on endpoint precision, feasibility, clinical meaning, ambiguity reduction, and implementation readiness rather than generic study design advice.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete conventional non-oncology diagnostic machine-learning research designs from a user-provided disease context, optional mechanism theme, and validation direction. Use when a study centers on disease-vs-control transcriptome comparison, optional mechanism-gene restriction, feature shrinkage, diagnostic model construction, ROC / calibration / DCA evaluation, interpretation layers, and orthogonal validation. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete tumor immune-infiltration-guided bulk-transcriptome diagnostic biomarker and machine-learning research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, immune infiltration estimation, immune-linked module discovery, consensus feature selection, diagnostic modeling, nomogram construction, clinical association, and optional prognostic extension or validation. Covers five study patterns (immune-cell-first diagnostic workflow, immune-module-to-biomarker workflow, consensus-ML biomarker workflow, diagnostic-plus-prognostic hybrid workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, reference literature pack, and self-critical risk review.

日本語の概要は準備中です。原文の説明を表示しています。

Designs complete research plans that integrate clinical variables with multi-omics data from a user-provided biomedical direction. Always use this skill whenever a user wants to design, scope, or structure a study that combines clinical variables with transcriptomics, proteomics, metabolomics, epigenomics, or related omics layers for mechanism interpretation, biomarker development, risk stratification, treatment-response analysis, or translational use. It should define the clinical use case, alignment across data layers, feature-reduction and fusion logic, modeling route, mechanism-interpretation layer, validation ladder, and four workload configurations (Lite / Standard / Advanced / Publication+). Never fabricate datasets, accession numbers, sample counts, metadata completeness, platform coverage, literature references, PMIDs, DOIs, or validation status. Always include the mandatory Dataset Disclaimer immediately before any workflow section that mentions datasets or public resources.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses whether study results are trustworthy by auditing design integrity, sample structure, statistical handling, bias control, validation chain, and claim discipline. It identifies where results are robust, fragile, overfit, under-validated, or overclaimed. Always separate reported findings from reliability judgment. Never fabricate references, PMIDs, DOIs, trial identifiers, study features, or validation claims.

日本語の概要は準備中です。原文の説明を表示しています。

Use when performing PCA principal component dimensionality reduction on tabular numeric data. Supports command-line parameter input, automatic numeric feature selection, parameter validation, result directory creation, and CSV or TXT format result export.

日本語の概要は準備中です。原文の説明を表示しています。